Clinical Significance of the Interleukin 24 mRNA Level in Head and Neck Squamous Cell Carcinoma and Its Subgroups: An In Silico Investigation

Table 3

The relationships between IL24 mRNA levels and clinicopathologic features of the 502 cases of HNSCC patients detected by RNA-sequencing.

Parameters	n	Mean	±SD	t	value
Tissue
HNSCC	502	4.035	±0.1973	10.504	<0.0001
Non-HNSCC	44	3.808	±0.1306
Gender
Male	368	4.026	±0.2058	−1.853	0.065
Female	134	4.059	±0.1704
Age
≥60	256	4.031	±0.2038	−0.347	0.729
<60	245	4.037	±0.2039
Grade
G1-G2	362	4.053	±0.1961	2.771	0.006
G3-G4	121	3.996	±0.1891
Pathological stage
I-II	114	4.051	±0.2025	1.047	0.296
III-IV	374	4.028	±0.1964
Pathological T stage
T1-T2	177	4.027	±0.1909	−0.561	0.575
T3-T4	310	4.037	±0.2021
Pathological N stage
N0	239	4.037	±0.1894	0.643	0.521
N1	241	4.025	±0.2061
Pathological M stage
M0	472	4.032	±0.1975	−0.112	0.911
M1	5	4.042	±0.2353

Note: HNSCC: head and neck squamous cell carcinoma; G: grade; T: tumor; N: lymph node; M: metastasis.